C-reactive Protein and Future Risk of Clinical and Molecular Subtypes of Colorectal Cancer.
Stina BodénRobin MyteJustin HarbsAnneli SundkvistCarl ZingmarkAnna Löfgren BurströmRichard PalmqvistSophia HarlidBethany Van GuelpenPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
Future efforts to establish the putative role of chronic, low-grade inflammation in colorectal cancer development will need to address the complex relationship between systemic inflammatory factors and tumor microenvironment, and might consider larger biomarker panels than CRP alone.